JERYL L HILLEMAN Insider Trading $XENT Intersect ENT, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JERYL L HILLEMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JERYL L HILLEMAN. JERYL L HILLEMAN is Exec. Vice President and CFO in SYMYX TECHNOLOGIES INC ($SMMX) and Senior Vice President & CFO in SYMYX TECHNOLOGIES INC ($SMMX) and Sr. Vice President and CFO in SYMYX TECHNOLOGIES INC ($SMMX) and Director in XENOPORT INC ($XNPT) and Chief Financial Officer in Intersect ENT, Inc. ($XENT) and in SI-BONE, Inc. ($SIBN) and Director in Talis Biomedical Corp ($TLIS) and Director in Minerva Neurosciences, Inc. ($NERV) and Director in NovoCure Ltd ($NVCR).
JERYL L HILLEMAN in Intersect ENT, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JERYL L HILLEMAN: Chief Financial Officer
Holdings: 43,836 shares
Current Value: $589,594
Latest Transaction: May 08 2019
$XENT Market Capitalization: $369.90M
$XENT Previous Close: $13.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JERYL L HILLEMAN in Intersect ENT, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XENT, NERV, NVCR, SIBN, SMMX, TLIS, XNPT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 08 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Grant | A | 0.00 | 11,952 | 0 | 43,836 | 31.9 K to 43.8 K (+37.49 %) |
| Apr 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 13.05 | 4,709 | 61,452 | 30,625 | |
| Apr 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 18.90 | 16,491 | 311,680 | 58,509 | |
| Apr 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 13.05 | 30,000 | 391,500 | 35,334 | |
| Apr 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 32.34 | 4,709 | 152,299 | 31,884 | 36.6 K to 31.9 K (-12.87 %) |
| Apr 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 32.34 | 16,491 | 533,354 | 36,593 | 53.1 K to 36.6 K (-31.07 %) |
| Apr 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 13.05 | 4,709 | 61,452 | 53,084 | 48.4 K to 53.1 K (+9.73 %) |
| Apr 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 18.90 | 16,491 | 311,680 | 48,375 | 31.9 K to 48.4 K (+51.72 %) |
| Apr 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 32.07 | 30,000 | 962,091 | 31,884 | 61.9 K to 31.9 K (-48.48 %) |
| Apr 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 13.05 | 30,000 | 391,500 | 61,884 | 31.9 K to 61.9 K (+94.09 %) |
| Jan 18 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | A | 28.58 | 56,000 | 1,600,480 | 56,000 | |
| Jan 18 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Grant | A | 0.00 | 12,000 | 0 | 31,884 | 19.9 K to 31.9 K (+60.35 %) |
| Jan 03 2019 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Payment of Exercise | F | 26.57 | 3,548 | 94,261 | 19,884 | 23.4 K to 19.9 K (-15.14 %) |
| Oct 10 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 8,167 | 90,817 | 0 | |
| Oct 10 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 13.05 | 4,666 | 60,891 | 65,334 | |
| Oct 10 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 27.99 | 12,833 | 359,253 | 23,432 | 36.3 K to 23.4 K (-35.39 %) |
| Oct 10 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 13.05 | 4,666 | 60,891 | 36,265 | 31.6 K to 36.3 K (+14.77 %) |
| Oct 10 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 8,167 | 90,817 | 31,599 | 23.4 K to 31.6 K (+34.85 %) |
| Sep 18 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,833 | 142,703 | 8,167 | |
| Sep 18 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 28.92 | 12,833 | 371,161 | 23,432 | 36.3 K to 23.4 K (-35.39 %) |
| Sep 18 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,833 | 142,703 | 36,265 | 23.4 K to 36.3 K (+54.77 %) |
| Jun 07 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,833 | 142,703 | 21,000 | |
| Jun 07 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 41.70 | 12,833 | 535,145 | 23,432 | 36.3 K to 23.4 K (-35.39 %) |
| Jun 07 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,833 | 142,703 | 36,265 | 23.4 K to 36.3 K (+54.77 %) |
| May 07 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,833 | 142,703 | 33,833 | |
| May 07 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 39.94 | 12,833 | 512,568 | 23,432 | 36.3 K to 23.4 K (-35.39 %) |
| May 07 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,833 | 142,703 | 36,265 | 23.4 K to 36.3 K (+54.77 %) |
| Apr 04 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,833 | 142,703 | 46,666 | |
| Apr 04 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 37.66 | 12,833 | 483,247 | 23,432 | 36.3 K to 23.4 K (-35.39 %) |
| Apr 04 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,833 | 142,703 | 36,265 | 23.4 K to 36.3 K (+54.77 %) |
| Mar 07 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,833 | 142,703 | 59,499 | |
| Mar 07 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 35.92 | 12,833 | 460,970 | 23,432 | 36.3 K to 23.4 K (-35.39 %) |
| Mar 07 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,833 | 142,703 | 36,265 | 23.4 K to 36.3 K (+54.77 %) |
| Feb 07 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,833 | 142,703 | 72,332 | |
| Feb 07 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 35.80 | 12,833 | 459,394 | 12,932 | 25.8 K to 12.9 K (-49.81 %) |
| Feb 07 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,833 | 142,703 | 25,765 | 12.9 K to 25.8 K (+99.23 %) |
| Jan 19 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | A | 33.95 | 49,000 | 1,663,550 | 49,000 | |
| Jan 19 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Grant | A | 0.00 | 10,500 | 0 | 23,432 | 12.9 K to 23.4 K (+81.19 %) |
| Jan 12 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,835 | 142,725 | 85,165 | |
| Jan 12 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 33.81 | 12,835 | 433,890 | 12,932 | 25.8 K to 12.9 K (-49.81 %) |
| Jan 12 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,835 | 142,725 | 25,767 | 12.9 K to 25.8 K (+99.25 %) |
| Jan 03 2018 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Payment of Exercise | F | 33.93 | 2,068 | 70,173 | 12,932 | 15 K to 12.9 K (-13.79 %) |
| Dec 05 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,833 | 142,703 | 98,000 | |
| Dec 05 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 30.06 | 12,833 | 385,813 | 15,000 | 27.8 K to 15 K (-46.11 %) |
| Dec 05 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,833 | 142,703 | 27,833 | 15 K to 27.8 K (+85.55 %) |
| Nov 06 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,833 | 142,703 | 110,833 | |
| Nov 06 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 27.78 | 12,833 | 356,529 | 15,000 | 27.8 K to 15 K (-46.11 %) |
| Nov 06 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,833 | 142,703 | 27,833 | 15 K to 27.8 K (+85.55 %) |
| Oct 05 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,833 | 142,703 | 123,666 | |
| Oct 05 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 29.96 | 12,833 | 384,500 | 15,000 | 27.8 K to 15 K (-46.11 %) |
| Oct 05 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,833 | 142,703 | 27,833 | 15 K to 27.8 K (+85.55 %) |
| Sep 06 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,833 | 142,703 | 136,499 | |
| Sep 06 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 31.05 | 12,833 | 398,462 | 15,000 | 27.8 K to 15 K (-46.11 %) |
| Sep 06 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,833 | 142,703 | 27,833 | 15 K to 27.8 K (+85.55 %) |
| Aug 07 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,833 | 142,703 | 149,332 | |
| Aug 07 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 29.00 | 12,833 | 372,210 | 15,000 | 27.8 K to 15 K (-46.11 %) |
| Aug 07 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,833 | 142,703 | 27,833 | 15 K to 27.8 K (+85.55 %) |
| Jul 12 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | M | 11.12 | 12,835 | 142,725 | 162,165 | |
| Jul 12 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Sell | S | 27.18 | 12,835 | 348,818 | 15,000 | 27.8 K to 15 K (-46.11 %) |
| Jul 12 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Buy | M | 11.12 | 12,835 | 142,725 | 27,835 | 15 K to 27.8 K (+85.57 %) |
| Jan 20 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | A | 13.05 | 70,000 | 913,500 | 70,000 | |
| Jan 20 2017 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Jan 20 2016 | XENT | Intersect ENT, Inc ... | HILLEMAN JERYL L | Chief Financial Off ... | Option Exercise | A | 18.90 | 75,000 | 1,417,500 | 75,000 |
Page: 1